Display options
Share it on

World J Hepatol. 2016 Nov 28;8(33):1442-1451. doi: 10.4254/wjh.v8.i33.1442.

Performance of cold-preserved rat liver Microorgans as the biological component of a simplified prototype model of bioartificial liver.

World journal of hepatology

María Dolores Pizarro, María Gabriela Mediavilla, Alejandra Beatriz Quintana, Ángel Luis Scandizzi, Joaquín Valentín Rodriguez, María Eugenia Mamprin

Affiliations

  1. María Dolores Pizarro, Joaquín Valentín Rodríguez, Centro Binacional de Criobiología Clínica y Aplicada, Rosario 2000, Argentina.

PMID: 27957242 PMCID: PMC5124715 DOI: 10.4254/wjh.v8.i33.1442

Abstract

AIM: To develop a simplified bioartificial liver (BAL) device prototype, suitable to use freshly and preserved liver Microorgans (LMOs) as biological component.

METHODS: The system consists of 140 capillary fibers through which goat blood is pumped. The evolution of hematocrit, plasma and extra-fiber fluid osmolality was evaluated without any biological component, to characterize the prototype. LMOs were cut and cold stored 48 h in BG35 and ViaSpan

RESULTS: The concentrations of ammonia and glucose, and the fluids osmolalities were matched after the first hour of perfusion, showing a proper exchange between blood and the biological compartment in the minibioreactor. After 120 min of perfusion, LMOs cold preserved in BG35 and ViaSpan

CONCLUSION: This prototype relied on a simple design and excellent performance. It's a practical tool to evaluate the detoxification ability of LMOs subjected to different preservation protocols.

Keywords: Acute liver failure; BG35 preservation solution; Bioartificial liver device; Cold preservation; Rat liver Microorgans

Conflict of interest statement

Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.

References

  1. World J Gastroenterol. 2005 Apr 7;11(13):1957-64 - PubMed
  2. Cell Res. 2016 Feb;26(2):206-16 - PubMed
  3. Ann Hepatol. 2011 Apr-Jun;10(2):196-206 - PubMed
  4. Artif Organs. 2008 Apr;32(4):323-8 - PubMed
  5. Clin Chem. 1979 Aug;25(8):1388-93 - PubMed
  6. J Pharmacol Exp Ther. 2002 Sep;302(3):861-70 - PubMed
  7. Science. 2002 Feb 8;295(5557):1005-9 - PubMed
  8. Transpl Int. 2002 Jun;15(6):278-89 - PubMed
  9. Cryobiology. 2000 May;40(3):270-6 - PubMed
  10. Cryobiology. 2012 Dec;65(3):179-87 - PubMed
  11. Cryo Letters. 2008 Mar-Apr;29(2):121-33 - PubMed
  12. Artif Organs. 2006 Dec;30(12):906-14 - PubMed
  13. J Clin Exp Hepatol. 2015 Jun;5(2):107-22 - PubMed
  14. Int J Med Sci. 2015 Feb 08;12(3):248-55 - PubMed
  15. Cryo Letters. 2002 Jul-Aug;23(4):245-54 - PubMed
  16. Adv Drug Deliv Rev. 2014 Apr;69-70:132-57 - PubMed
  17. Ann Hepatol. 2014 Mar-Apr;13(2):256-64 - PubMed
  18. Cell Transplant. 2012;21(9):2079-88 - PubMed
  19. Toxicol Appl Pharmacol. 2013 Apr 1;268(1):1-16 - PubMed
  20. Xenobiotica. 1998 Apr;28(4):349-60 - PubMed
  21. Int J Artif Organs. 1996 Nov;19(11):645-54 - PubMed
  22. Transplantation. 1988 Apr;45(4):673-6 - PubMed
  23. Clin Chim Acta. 1974 Oct 30;56(2):151-7 - PubMed
  24. Cryobiology. 1980 Dec;17(6):540-8 - PubMed
  25. Biointerphases. 2010 Sep;5(3):FA116-31 - PubMed
  26. Eur J Med Res. 2012 May 25;17:13 - PubMed
  27. Drug Metab Dispos. 2013 Mar;41(3):562-7 - PubMed
  28. PLoS One. 2013 Dec 18;8(12):e82312 - PubMed
  29. Cryo Letters. 2012 Jan-Feb;33(1):75-85 - PubMed
  30. J Hepatol. 2004 Dec;41(6):950-6 - PubMed

Publication Types